Evidence map›Paper›PMID 34827461›Full record

ArticleBrain sciences2021

Corpus Callosotomy in 3 Cavalier King Charles Spaniel Dogs with Drug-Resistant Epilepsy.

Rikako Asada, Satoshi Mizuno, Yoshihiko Yu, Yuji Hamamoto, Tetsuya Anazawa, Daisuke Ito, Masato Kitagawa, Daisuke Hasegawa

Open access · goldAbstract readCase Reports
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Corpus Callosotomy: Editorial.Brain sciences · 2022
    Article
  6. Dogs as a Natural Animal Model of Epilepsy.Frontiers in veterinary science · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rikako AsadaLaboratory of Veterinary Radiology, Nippon Veterinary and Life Science University, Musashino 180-8602, Japan.
Satoshi MizunoLaboratory of Veterinary Radiology, Nippon Veterinary and Life Science University, Musashino 180-8602, Japan.
Yoshihiko YuLaboratory of Veterinary Radiology, Nippon Veterinary and Life Science University, Musashino 180-8602, Japan.
Yuji HamamotoVeterinary Medical Teaching Hospital, Nippon Veterinary and Life Science University, Musashino 180-8602, Japan.
Tetsuya AnazawaNeurology and Neurosurgery Service, Japan Animal Referral Medical Center Nagoya, Nagoya 468-0003, Japan.
Daisuke ItoLaboratory of Veterinary Neurology, Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, Fujisawa 252-0880, Japan.
Masato KitagawaLaboratory of Veterinary Neurology, Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, Fujisawa 252-0880, Japan.
Daisuke HasegawaLaboratory of Veterinary Radiology, Nippon Veterinary and Life Science University, Musashino 180-8602, Japan.ORCID 0000-0002-7554-9108
Nippon Veterinary and Life Science University · JPNihon University · JPNagoya Medical Center · JP

Funding

Japan Society for the Promotion of Science 17H01507
6 · The paper itself

Abstract

Corpus callosotomy (CC) is an established palliative surgery for human patients with drug-resistant epilepsy (DRE), especially those with generalized seizures and multiple or unknown epileptogenic focus. However, there are no reports to describe CC in canine patients with epilepsy. Three client-owned Cavalier King Charles Spaniels with DRE are included in this case series. In presurgical evaluations, an apparent epileptogenic zone was not detected in each dog and CC was conducted. Total CC was performed in one dog, whereas the other two received partial CC. One dog recovered from surgery without any complications, but died suddenly by an unknown cause at 10 h after surgery. For the other two dogs, postoperative evaluations including seizure outcomes, complications, and quality of life of the dogs and owners were assessed for at least 12 months. Both dogs showed a remarkable decrease in seizure frequency (averaged 80.3% reduction) and severity after surgery. The antiseizure medications were maintained, and not only the mentation and activity of the dogs, but also the quality of life of dogs and owners were improved postoperatively. Although technical improvement and more large-scale studies are needed, CC is a treatment option for dogs with DRE in veterinary medicine.

Indexed as

corpus callosotomydogdrug-resistant epilepsyepilepsy surgeryveterinary

Identifiers

PMID34827461
PMCPMC8615928
OpenAlexW3210460156

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.